PDS Biotechnology Corporation PDSB
$ 5.91
-5.29%
Quarterly report 2024-Q2
added 08-13-2024
PDS Biotechnology Corporation Financial Ratios 2011-2024 | PDSB
Annual Financial Ratios PDS Biotechnology Corporation
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-16.8 | -8.7 | -24.2 | -3.2 | -1.8 | -0.3 | -7.6 | -7.2 | -3.2 | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-1.4 | -1.4 | -0.7 | -0.9 | 1.4 | 1.1 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
160 M | 126 M | 91.8 M | 21.8 M | 3.39 M | -15.4 M | 330 M | 196 M | -28.7 M | 31.2 M | 16.2 M | - | - |
EBITDA per Share |
-1.39 | -1.46 | -0.84 | -0.969 | -3.69 | -19.3 | -34.1 | -27.3 | -65.4 | - | - | - | - |
EV/EBITDA |
-3.1 | -1.4 | -0.0 | 0.7 | -6.2 | -4.8 | 1.3 | - | - | - | - | ||
PEG |
0.85 | 0.32 | 0.65 | 0.03 | -0.02 | -0.01 | 0.31 | -0.11 | 0.02 | - | - | - | - |
P/B |
7.0 | 3.8 | 2.4 | 1.7 | 1.1 | 0.4 | 6.2 | 3.1 | 0.7 | - | - | - | - |
P/CF |
-5.4 | -6.5 | -12.3 | -3.6 | -0.7 | -0.4 | -9.5 | -8.5 | -3.9 | - | - | - | - |
ROE % |
-41.71 | -43.49 | -10.00 | -54.73 | -59.83 | -136.96 | -81.54 | -43.48 | -22.93 | - | - | - | - |
ROA % |
-18.35 | -24.85 | -9.41 | -48.06 | -48.30 | -112.83 | -54.91 | -35.00 | -20.94 | - | - | - | - |
ROCE % |
-164.73 | -94.71 | -33.92 | -53.96 | -154.39 | -101.74 | -65.16 | -37.91 | -21.11 | - | - | - | - |
Current Ratio |
1.8 | 2.3 | 16.9 | 9.3 | 5.2 | 5.6 | 6.9 | 16.1 | 15.3 | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios PDS Biotechnology Corporation
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.23 | -0.3 | - | -0.35 | -0.37 | -0.32 | - | -0.26 | -0.2 | -0.32 | - | -0.24 | -0.03 | -0.14 | - | -0.21 | -0.19 | -0.39 | - | -1.1 | -0.75 | 1.82 | - | -0.21 | -0.17 | -0.24 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.29 | - | - | - | -0.31 | - | -0.26 | -0.25 | -0.32 | - | -0.24 | -0.22 | -0.14 | - | -0.21 | -0.19 | -0.39 | - | -1.1 | -0.81 | -1.31 | - | -0.21 | -0.17 | -0.24 | -0.52 | -0.35 | -0.43 | -0.41 | -0.38 | -0.35 | -0.32 | -0.31 | -0.31 | -5 | -2.92 | -2.47 | -2.38 | -2.09 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-144.08 | -152.69 | -103.42 | -119.20 | -90.66 | -66.42 | -42.26 | -52.52 | -47.00 | -36.49 | -23.57 | -37.97 | -42.11 | -52.10 | -39.88 | -89.05 | -123.83 | -146.25 | -24.11 | 17.71 | 108.70 | 175.31 | 118.61 | 2399.88 | 2339.97 | 2284.93 | 2222.02 | -69.91 | -63.87 | -52.73 | -43.48 | -39.32 | -35.54 | -29.55 | -22.93 | -5.06 | 15.85 | 20.36 | 24.00 | 12.64 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-67.07 | -71.40 | -51.18 | -61.09 | -52.03 | -44.33 | -34.19 | -43.89 | -43.68 | -34.05 | -21.44 | -34.09 | -37.03 | -45.75 | -35.03 | -74.72 | -101.77 | -119.10 | -19.47 | -226.02 | -392.88 | -530.98 | -585.77 | -600.78 | -406.41 | -256.08 | -54.91 | -48.48 | -46.00 | -39.87 | -35.00 | -32.36 | -30.21 | -25.88 | -20.94 | -33.78 | -46.86 | -42.74 | -39.41 | -20.64 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-141.18 | -152.22 | -105.07 | -120.54 | -93.04 | -67.70 | -44.44 | -54.70 | -49.49 | -42.69 | -29.77 | -44.17 | -48.31 | -52.13 | -40.08 | -90.07 | -125.66 | -151.35 | -128.69 | -86.93 | 4.83 | 74.69 | 118.45 | 2763.77 | 2704.52 | 2650.10 | 2587.86 | -69.72 | -63.75 | -53.05 | -44.26 | -39.25 | -34.66 | -28.34 | -21.64 | 0.04 | 19.76 | 23.81 | 27.22 | 12.79 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.0 | 2.2 | 1.8 | 1.8 | 2.0 | 2.5 | 2.3 | 2.7 | 12.2 | 11.8 | 16.9 | 18.4 | 17.6 | 8.2 | 8.2 | 8.2 | 8.2 | 8.2 | 5.2 | - | - | 5.2 | 0.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency